NCT00235274View on ClinicalTrials.gov

Effects of RG1068 (Secretin) on Information Processing in Schizophrenia

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 30, 2005

Study Completion Date

August 31, 2006

Conditions
Schizophrenia
Interventions
DRUG

Subcutaneous Secretin

Trial Locations (1)

46202

LaRue Carter Hospital, Indianapolis

All Listed Sponsors
collaborator

Shekhar, Anantha M.D., Ph.D.

INDIV

collaborator

Repligen Corporation

INDUSTRY

lead

Indiana University School of Medicine

OTHER

NCT00235274 - Effects of RG1068 (Secretin) on Information Processing in Schizophrenia | Biotech Hunter | Biotech Hunter